Effect of Aterial Stiffness on Myocardial Work in Patients With Hypertension

Sponsor
Chongqing Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04573257
Collaborator
(none)
160
1
5.7
28.3

Study Details

Study Description

Brief Summary

Hypertension is a serious threat to human health and a major global economic burden.Chronic hypertension can cause left ventricular remodeling and loss of function, eventually leading to heart failure.Exploring the early changes and mechanisms of left ventricular cardiac function caused by hypertension, and to identify individuals who may develop into serious heart injury, may play a positive role in the early prevention and control of heart failure caused by hypertension.Therefore, this study intend to use two-dimensional speckle tracking technology, a non-invasive method to measure left ventricular pressure-strain loop to quantitatively reflect cardiac work index , to study different hypertension patients with normal left ventricular ejection fraction the change of the global and local cardiac work, and the influence of aterosclerosis in thes patients to myocardial work, and explore their relationship with ventricular remodeling and abnormal diastolic function.To improve the understanding of the pathophysiology of hypertension, hypertensive heart disease and heart failure, and to provide scientific support for the early prevention and control of such diseases.

Condition or Disease Intervention/Treatment Phase
  • Other: Echocardiography and pulse wave velocity measurement

Detailed Description

Hypertension is a serious threat to human health and a major global economic burden.Chronic hypertension can cause left ventricular remodeling and loss of function, eventually leading to heart failure. Ventricular remodeling in hypertensive patients is an adaptive and decompensating response to persistent elevated blood pressure and increased myocardial work load. Exploring the early changes and mechanisms of left ventricular cardiac function caused by hypertension, and to identify individuals who may develop into serious heart injury, may play a positive role in the early prevention and control of heart failure caused by hypertension.Therefore, this study intend to use two-dimensional speckle tracking technology, a non-invasive method to measure left ventricular pressure-strain loop to quantitatively reflect cardiac work index , to study different hypertension patients with normal left ventricular ejection fraction (including hypertension without heart damage performance with different degree of high blood pressure, hypertension with diastolic dysfunction , hypertension with left ventricular hypertrophy ) the change of the global and local cardiac work, and the influence of aterosclerosis in thes patients to myocardial work, and explore their relationship with ventricular remodeling and abnormal diastolic function.To improve the understanding of the pathophysiology of hypertension, hypertensive heart disease and heart failure, and to provide scientific support for the early prevention and control of such diseases.

Study Design

Study Type:
Observational
Anticipated Enrollment :
160 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Relationship Between Arteriosclerosis and Myocardial Work in Hypertensive Patients With Left Ventricular Ejection Fraction Retention
Actual Study Start Date :
Sep 10, 2020
Anticipated Primary Completion Date :
Jan 1, 2021
Anticipated Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
normotensive group

The medical history and basic examination and examination information were collected. Echocardiography including conventional cardiac ultrasound, tissue Doppler and two-dimensional speckle tracking to measure myocardial strain and noninvasive myocardial work were carried out , and the brachial-ankle pulse wave velocity was measured in parallel.

Other: Echocardiography and pulse wave velocity measurement
Echocardiography(Conventional ultrasonic imaging,tissue Doppler imaging and non invasive myocardial work) and pulse wave velocity measurement

Prehypertension group

The medical history and basic examination and examination information were collected. Echocardiography including conventional cardiac ultrasound, tissue Doppler and two-dimensional speckle tracking to measure myocardial strain and noninvasive myocardial work were carried out , and the brachial-ankle pulse wave velocity was measured in parallel.

Other: Echocardiography and pulse wave velocity measurement
Echocardiography(Conventional ultrasonic imaging,tissue Doppler imaging and non invasive myocardial work) and pulse wave velocity measurement

hypertensive group

The medical history and basic examination and examination information were collected. Echocardiography including conventional cardiac ultrasound, tissue Doppler and two-dimensional speckle tracking to measure myocardial strain and noninvasive myocardial work were carried out , and the brachial-ankle pulse wave velocity was measured in parallel.

Other: Echocardiography and pulse wave velocity measurement
Echocardiography(Conventional ultrasonic imaging,tissue Doppler imaging and non invasive myocardial work) and pulse wave velocity measurement

Outcome Measures

Primary Outcome Measures

  1. myocardial work [2020.09-2021.01]

    myocardial work measured by non-invasive left ventricular pressure-strain loop(2D speckle tracking echocardiography method by using the GE Vivid E95 ultrasound system )

Secondary Outcome Measures

  1. brachial-ankle pulse wave velocity [2020.09-2021.01]

    brachial-ankle pulse wave velocity measured by OMRON BP-203RPEIII arteriosclerosis detector

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Age 18-65 years

The diagnostic criteria of hypertension were blood pressure systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg in the clinic or receiving antihypertensive drug treatment

The normal high-value diagnostic criteria for hypertension were systolic blood pressure 130-139mmhg and or diastolic blood pressure 85-90mmhg in the clinic

LVEF > 50%

Exclusion Criteria:

coronary atherosclerotic heart disease or symptoms of angina

Cardiomyopathy

Valvular heart disease

Diabetes

Atrial fibrillation

Renal function damage

Pregnancy

Secondary hypertension

Chemotherapy for malignant tumors

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Affiliated Hospital of Chongqing Medical University Chongqing China 400000

Sponsors and Collaborators

  • Chongqing Medical University

Investigators

  • Principal Investigator: QIN DUAN, First Affiliated Hospital of Chongqing Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dongying Zhang, professor, Chongqing Medical University
ClinicalTrials.gov Identifier:
NCT04573257
Other Study ID Numbers:
  • 20200910
First Posted:
Oct 5, 2020
Last Update Posted:
Oct 5, 2020
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dongying Zhang, professor, Chongqing Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2020